China Universal Asset Management Company’s Palisade Bio PALI Stock Holding History

China Universal Asset Management Company’s Portfolio PALI Stock Details PALI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$142K	Buy	+67,890	New	+$134K	0.01%	385

Other funds holding PALI

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

BGI

B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

China Universal Asset Management Company's PALI Position: Q2 2026 in Review

China Universal Asset Management Company opened a new position in Palisade Bio (PALI) in Q2 2026: 67,890 shares worth $142K. The stake represents 0.01% of the portfolio and ranks #385 among its holdings.

124 funds tracked by Wall St. Rank hold PALI as of Q2 2026.

China Universal Asset Management Company held 67,890 shares of Palisade Bio worth $142K as of Q2 2026.
Palisade Bio was a new China Universal Asset Management Company position in Q2 2026.
Palisade Bio made up 0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #385 holding.
124 funds tracked by Wall St. Rank held Palisade Bio as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.